Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: A comparison with fecal calprotectin in clinical setting

Journal of Clinical Gastroenterology

Volumn 49, Issue 3, 2015, Pages 218-221

  Tursi, Antonio ^a   Elisei, Walter ^b   Picchio, Marcello ^c   Giorgetti, Gian M ^d   Brandimarte, Giovanni ^e  

^a ASL BAT   (Italy)

^b ASL RMH   (Italy)

^c Hospital P Colombo   (Italy)

^d Division of Surgery   (Italy)

^e Cristo Re Hospital   (Italy)

Author keywords

Clinical setting; Fecal calprotectin; Irritable bowel syndrome; Symptomatic uncomplicated diverticular disease

Indexed keywords

CALGRANULIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHRONIC PAIN; COLON DIVERTICULOSIS; COLONOSCOPY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; FECES ANALYSIS; FECES LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; IRRITABLE COLON; LEFT LOWER ABDOMINAL PAIN; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPID TEST; SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE; ABDOMINAL PAIN; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIVERTICULOSIS, COLONIC; FECES; IRRITABLE BOWEL SYNDROME; ITALY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PAIN MEASUREMENT; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ABDOMINAL PAIN; AGED; BIOMARKERS; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIVERTICULOSIS, COLONIC; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; ITALY; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84922710986     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000094     Document Type: Article

References (19)

1. Humes DJ. Changing epidemiology: does it increase our understanding? Dig Dis. 2012;30:6-11.
2. Clemens CH, Samsom M, Roelofs J, et al. Colorectal visceral perception in diverticular disease. Gut. 2004;53:717-722.
3. Spiller RC. Is it diverticular disease or is it irritable bowel syndrome? Dig Dis. 2012;30:64-69.
4. Annibale B, Lahner E, Maconi G, et al. Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey. Int J Colorectal Dis. 2012;27:1151-1159.
5. Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003;35:642-647.
6. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506-513.
7. Røseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein digestion. Digestion. 1997;58: 176-180.
8. Røseth AG, Fagerhol M, Aadland E, et al. Assessment of neutrophil dominating protein calprotectin in feces. A methodological study. Scand J Gastroenterol. 1992;27:793-798.
9. Teahon K, Roseth AG, Foster R, et al. Fecal calprotectin: a simple sensitive quantitative measure of intestinal inflammation in man. Gastroenterology. 1997;112(suppl):A1103.
10. Vestergaard TA, Nielsen SL, Dahlerup JF, et al. Fecal calprotectin: assessment of a rapid test. Scand J Clin Lab Invest. 2008;68:343-347.
11. Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis. 2008;23:985-992.
12. Tursi A, Brandimarte G, Elisei W, et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis. 2009;24:49-55.
13. Drossman DA, Corazziari E, Delvaux M, et al. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean: Degnon Associates; 2006.
14. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712-721.
15. Jung HK, Choung RS, Locke GR IIIrd, et al. Diarrheapredominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010;105:652-661.
16. Tibble JA, Sigthorsson G, Foster R, et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology. 2002;123:450-460.
17. Ishihara S, Yashima K, Kushiyama Y, et al. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol. 2012;47:1084-1090.
18. Gu HX, Zhang YL, Zhi FC, et al. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case-control study. Int J Colorectal Dis. 2011;26:935-940.
19. Hall JF, Roberts PL, Ricciardi R, et al. Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum. 2011;54:283-288.